Author:
Zhuang Sen H.,Xiu Liang,Elsayed Yusri A.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference31 articles.
1. Statistical Issues in Drug Development, Second Edition. Statistics in Practice Series. 8.2.7: Using Surrogate Endpoints.;Senn,2008
2. End points and United States food and drug administration approval of oncology drugs.;Johnson;J Clin Oncol,2003
3. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.;Clin Pharmacol Ther,2001
4. Guidance for Industry Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics.,2007
5. Estimating the cost of new drug development: is it really 802 million dollars?;Adams;Health Aff (Millwood),2006
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献